Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

L-ficolin binds to the glycoproteins hemagglutinin and neuraminidase and inhibits influenza A virus infection both in vitro and in vivo.

Pan Q, Chen H, Wang F, Jeza VT, Hou W, Zhao Y, Xiang T, Zhu Y, Endo Y, Fujita T, Zhang XL.

J Innate Immun. 2012;4(3):312-24. doi: 10.1159/000335670. Epub 2012 Mar 2.

2.

Mice deficient in ficolin, a lectin complement pathway recognition molecule, are susceptible to Streptococcus pneumoniae infection.

Endo Y, Takahashi M, Iwaki D, Ishida Y, Nakazawa N, Kodama T, Matsuzaka T, Kanno K, Liu Y, Tsuchiya K, Kawamura I, Ikawa M, Waguri S, Wada I, Matsushita M, Schwaeble WJ, Fujita T.

J Immunol. 2012 Dec 15;189(12):5860-6. doi: 10.4049/jimmunol.1200836. Epub 2012 Nov 12.

3.

Immune effects against influenza A virus and a novel DNA vaccine with co-expression of haemagglutinin- and neuraminidase-encoding genes.

Zhang W, Li W, Li Y, Li H, Wang B, Wang F, Zhu Y, Jiang Z, Zhong L, Li M.

J Med Microbiol. 2009 Jul;58(Pt 7):845-54. doi: 10.1099/jmm.0.006825-0. Epub 2009 Jun 4.

PMID:
19498203
4.

A novel measurement method for activation of the lectin complement pathway via both mannose-binding lectin (MBL) and L-ficolin.

Inoshita H, Matsushita M, Koide S, Kusaba G, Ishii M, Onda K, Gi MJ, Nakata M, Ohsawa I, Horikoshi S, Ohi H, Tomino Y.

J Immunol Methods. 2009 Sep 30;349(1-2):9-17. doi: 10.1016/j.jim.2009.08.005. Epub 2009 Aug 20.

PMID:
19699205
5.

M-ficolin, an innate immune defence molecule, binds patterns of acetyl groups and activates complement.

Frederiksen PD, Thiel S, Larsen CB, Jensenius JC.

Scand J Immunol. 2005 Nov;62(5):462-73.

6.

Recombinant chimeric lectins consisting of mannose-binding lectin and L-ficolin are potent inhibitors of influenza A virus compared with mannose-binding lectin.

Chang WC, Hartshorn KL, White MR, Moyo P, Michelow IC, Koziel H, Kinane BT, Schmidt EV, Fujita T, Takahashi K.

Biochem Pharmacol. 2011 Feb 1;81(3):388-95. doi: 10.1016/j.bcp.2010.10.012. Epub 2010 Oct 28.

7.

Efficacy of recombinant chimeric lectins, consisting of mannose binding lectin and L-ficolin, against influenza A viral infection in mouse model study.

Takahashi K, Moyo P, Chigweshe L, Chang WC, White MR, Hartshorn KL.

Virus Res. 2013 Dec 26;178(2):495-501. doi: 10.1016/j.virusres.2013.10.001. Epub 2013 Oct 16.

8.

Human H-ficolin inhibits replication of seasonal and pandemic influenza A viruses.

Verma A, White M, Vathipadiekal V, Tripathi S, Mbianda J, Ieong M, Qi L, Taubenberger JK, Takahashi K, Jensenius JC, Thiel S, Hartshorn KL.

J Immunol. 2012 Sep 1;189(5):2478-87. doi: 10.4049/jimmunol.1103786. Epub 2012 Jul 30.

9.

Studies of the pattern recognition molecule H-ficolin: specificity and purification.

Zacho RM, Jensen L, Terp R, Jensenius JC, Thiel S.

J Biol Chem. 2012 Mar 9;287(11):8071-81. doi: 10.1074/jbc.M111.301044. Epub 2012 Jan 11.

10.

Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase.

Tsai C, Caillet C, Hu H, Zhou F, Ding H, Zhang G, Zhou B, Wang S, Lu S, Buchy P, Deubel V, Vogel FR, Zhou P.

Vaccine. 2009 Nov 12;27(48):6777-90. doi: 10.1016/j.vaccine.2009.08.056. Epub 2009 Sep 2.

PMID:
19732860
11.

Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase.

Schmeisser F, Adamo JE, Blumberg B, Friedman R, Muller J, Soto J, Weir JP.

Vaccine. 2012 May 14;30(23):3413-22. doi: 10.1016/j.vaccine.2012.03.033. Epub 2012 Mar 29.

PMID:
22465746
12.

Human mannose-binding lectin and L-ficolin function as specific pattern recognition proteins in the lectin activation pathway of complement.

Ma YG, Cho MY, Zhao M, Park JW, Matsushita M, Fujita T, Lee BL.

J Biol Chem. 2004 Jun 11;279(24):25307-12. Epub 2004 Apr 12.

13.

Ficolin-2 defends against virulent Mycobacteria tuberculosis infection in vivo, and its insufficiency is associated with infection in humans.

Luo F, Sun X, Wang Y, Wang Q, Wu Y, Pan Q, Fang C, Zhang XL.

PLoS One. 2013 Sep 9;8(9):e73859. doi: 10.1371/journal.pone.0073859. eCollection 2013.

14.
15.

Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice.

Qiu M, Fang F, Chen Y, Wang H, Chen Q, Chang H, Wang F, Wang H, Zhang R, Chen Z.

Biochem Biophys Res Commun. 2006 May 19;343(4):1124-31. Epub 2006 Mar 23.

PMID:
16580631
16.
17.

Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.

de Wit E, Munster VJ, Spronken MI, Bestebroer TM, Baas C, Beyer WE, Rimmelzwaan GF, Osterhaus AD, Fouchier RA.

J Virol. 2005 Oct;79(19):12401-7.

18.

A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model.

Horimoto T, Takada A, Iwatsuki-Horimoto K, Kawaoka Y.

Vaccine. 2004 Jun 2;22(17-18):2244-7.

PMID:
15149783
19.

Interactions of ficolin and mannose-binding lectin with fibrinogen/fibrin augment the lectin complement pathway.

Endo Y, Nakazawa N, Iwaki D, Takahashi M, Matsushita M, Fujita T.

J Innate Immun. 2010;2(1):33-42. doi: 10.1159/000227805. Epub 2009 Jul 3.

20.

Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies.

Horváth A, Andersen I, Junker K, Lyck Fogh-Schultz B, Holm Nielsen E, Gizurarson S, Andersen O, Kármán J, Rajnavölgyi E, Erdei A, Svehag SE.

Antiviral Res. 2001 Oct;52(1):43-53.

PMID:
11530187

Supplemental Content

Support Center